PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury

Phenylacetylglutamine (PAGln), a gut microbiota (GM)-derived metabolite, is associated with cardiovascular disease. Studies have shown that disordered GM participated in the progression of atrial fibrillation (AF), but the relationship between PAGln and AF is unclear. This study investigated the cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chen, Zuo, Kun, Jiao, Kaicheng, Zhu, Xiaoming, Fu, Yuan, Zhong, Jiuchang, Xu, Li, Yang, Xinchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405855/
https://www.ncbi.nlm.nih.gov/pubmed/36009014
http://dx.doi.org/10.3390/biom12081120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405855/
https://www.ncbi.nlm.nih.gov/pubmed/36009014
http://dx.doi.org/10.3390/biom12081120

Ejemplares similares